Ascend Wellness Holdings LLC (AAWH) AI Stock Analysis
Ascend Wellness Holdings LLC
(Other OTC:AAWH)
No summary available
Ascend Wellness Holdings LLC (AAWH) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $81.08M
- Dividend Yield
- ―
- Average Volume (3M)
- 120.59K
- Price to Earnings (P/E)
- -0.7
- Beta (1Y)
- 0.71
- Revenue Growth
- -8.37%
- EPS Growth
- -32.53%
- Country
- US
- Employees
- 2,300
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Ascend Wellness Holdings LLC Business Overview & Revenue Model
Company Description
Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. Its cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related product...
Ascend Wellness Holdings LLC Earnings Call Summary
The call highlighted multiple operational and financial improvements: sequential revenue growth of 7.9%, retail-led expansion (+11.5% retail sales), adjusted EBITDA growth (~10.5%) and improving customer metrics (transactions +6.7%, traffic +20%, loyalty conversion). Product innovation and share gains were notable positives. Challenges include a modest wholesale decline (~1%), operational disruption from an Illinois union strike and a closed Michigan facility, lower-margin biomass sales, ongoing pricing pressure in some markets, and a reverse split proposal tied to uplisting efforts. On balance, positive momentum in retail densification, margin expansion and cash generation outweigh the transitory operational and market challenges.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Guidance for the next quarter calls for 2%–4% top-line growth driven by ramping new store openings and the M&A pipeline (partially offset by a month-long Illinois union strike that hit wholesale), with adjusted EBITDA margin expected to be similar to Q2’s 23.1% (Q2 results: $126.1M net revenue, $92.7M retail, $33.4M wholesale; adjusted EBITDA $29.1M; adjusted gross profit $58.3M and 46.2% margin), a full-year CapEx plan of about $20M (≈$11M deployed year-to-date, $5.8M in Q2) and liquidity of $67M at quarter end; the company expects to meet or exceed its 60‑store year‑end target (56 stores today) and is targeting a minimum ~35% return on invested capital for M&A.
Ascend Wellness Holdings LLC Risk Analysis
Ascend Wellness Holdings LLC disclosed 81 risk factors in its most recent earnings report. Ascend Wellness Holdings LLC reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
1 New RiskAscend Wellness Holdings LLC Peers Comparison
Overall Rating
TSE:GTII73Outperform
TSE:CURA59Neutral
TSE:VRNO51Neutral
TSE:CL45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TSE:GTII | 73Outperform | CAD 1.90B | 11.41 | 6.82% | ― | 3.81% | 344.13% |
| TSE:CURA | 59Neutral | CAD 3.12B | -60.28 | -4.47% | ― | 1.50% | 81.84% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:VRNO | 51Neutral | CAD 2.17B | -1.65 | -28.93% | ― | 0.61% | 37.92% |
| TSE:CL | 45Neutral | CAD 365.32M | -1.89 | -28.27% | ― | -5.83% | -115.39% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AAWH | Ascend Wellness Holdings Llc Class A | 0.40 | -0.31 | -43.80% | |
| TSE:CURA | Curaleaf Holdings (Otc) | 11.77 | 0.04 | 0.34% | |
| TSE:GTII | Green Thumb Industries (OTC) | 8.70 | -0.95 | -9.84% | |
| TSE:CL | Cresco Labs OTC | 0.80 | -0.83 | -50.92% | |
| TSE:VRNO | Verano Holdings Corp. | 6.32 | 0.00 | 0.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.